Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Scientists identify gene signatures in children with severe COVID-19 infection (opens in a new tab)

medicalxpress.com · 2026-10-07

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. 2 other points were not covered by the paper.

  • 4 supported
  • 1 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Four of seven check out. Two claims the study doesn't address.

  • 4 supported
  • 1 overstated
  • 2 not covered
Open claim evidence
3

The source study

Immune transcriptomic differences in paediatric patients with SARS-CoV-2 compared to other lower respiratory tract infections

BMC Infectious Diseases · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedThe findings, published in BMC Infectious Diseases, offer early clues about how the immune system responds to severe infections, which children are at higher risk and potential targets for treatment.View evidenceHide evidence

Why this verdict

The profile supports that the study provides transcriptomic clues about immune responses and candidate genes/pathways for future mechanistic or therapeutic investigation. However, the story’s statement that the findings offer clues about 'which children are at higher risk' goes beyond the abstract-level evidence: the paper is an observational, cross-sectional group comparison and the profile does not report prospective risk prediction or validated clinical risk stratification.

1

Study evidence

Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.

“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
2

Study evidence

WGCNA identified 10 correlated gene modules shared between paediatric LRTIs, interpreted as showing similar underlying response mechanisms across the studied respiratory infections.

“Weighted Gene Co-expression Network Analysis (WGCNA) identified 10 correlated gene modules shared between LRTIs showing similar underlying response mechanisms.”
Claim 2 of 7Not coveredResearchers from the University of Southampton and the University of Cape Town, together with international partners, analyzed gene expression in blood samples from 333 children from South Africa.View evidenceHide evidence

As stated333 children

Why this verdict

The abstract-level profile supports whole-blood transcriptome analysis and the stated cohort counts sum to 333 for the listed groups. However, the profile does not verify the named institutional affiliations or, at this depth, all geographic/partner details in the claim.

1

Study evidence

Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.

“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
Claim 3 of 7Not coveredThe researchers also identified 82 genes that helped distinguish mild or asymptomatic COVID-19 infection from severe cases, suggesting that gene expression patterns could be used as an indicator of disease severity.View evidenceHide evidence

As stated82 genes

Why this verdict

The profile supports the general idea that the study sought genes discriminating SARS-CoV-2 severity, but the abstract-level profile does not report an 82-gene panel, diagnostic performance, or validation details. The proposed use as an indicator of disease severity therefore cannot be verified at the supplied evidence depth.

1

Study evidence

Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.

“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
Claim 4 of 7SupportedResearchers have identified patterns of gene activity associated with severe COVID-19 in children that are shared with other serious respiratory infections.View evidenceHide evidence

Why this verdict

The abstract-level profile supports an observational whole-blood transcriptomic study in children comparing severe SARS-CoV-2 with other respiratory infection groups, and reports shared WGCNA co-expression modules across lower respiratory tract infections. The claim is framed associationally and hedged, so the headline does not overstate the paper at this depth.

1

Study evidence

Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.

“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
2

Study evidence

WGCNA identified 10 correlated gene modules shared between paediatric LRTIs, interpreted as showing similar underlying response mechanisms across the studied respiratory infections.

“Weighted Gene Co-expression Network Analysis (WGCNA) identified 10 correlated gene modules shared between LRTIs showing similar underlying response mechanisms.”
Claim 5 of 7SupportedThe team compared samples from children hospitalized with severe COVID-19, RSV and PTB infections with those from children with only mild or asymptomatic COVID-19 and a control group of healthy children.View evidenceHide evidence

Why this verdict

The profile states that whole-blood transcriptomes from healthy children, mild/asymptomatic SARS-CoV-2, severe SARS-CoV-2, RSV-LRTI and PTB groups were compared. The story’s comparison description is consistent with that abstract-level evidence, although it compresses the full comparator set.

1

Study evidence

Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.

“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
Claim 6 of 7SupportedThey identified more than 5,000 genes expressed differently in children with severe infections and 10 groups of genes expressed in a similar pattern across the different lower respiratory tract infections.View evidenceHide evidence

As statedmore than 5,000 genes; 10 groups of genes

Why this verdict

The profile reports more than 5,000 differentially expressed genes at FDR < 0.05 and a WGCNA result identifying 10 correlated gene modules shared between LRTIs. The wording is a simplified but acceptable rendering of the abstract-level findings.

1

Study evidence

Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.

“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
2

Study evidence

WGCNA identified 10 correlated gene modules shared between paediatric LRTIs, interpreted as showing similar underlying response mechanisms across the studied respiratory infections.

“Weighted Gene Co-expression Network Analysis (WGCNA) identified 10 correlated gene modules shared between LRTIs showing similar underlying response mechanisms.”
Claim 7 of 7SupportedThe team says further research with larger groups of children will be needed to determine whether these gene signature discoveries can be developed for clinical use.View evidenceHide evidence

Why this verdict

The profile notes that candidate genes, modules and pathways are proposed for future investigation and that the abstract does not report external validation or replication. The story’s caveat that larger studies are needed before clinical use is consistent with those limitations, even though the exact wording of an author statement is not independently verified in the abstract-level profile.

1

Study evidence

Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.

“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
2

Study evidence

WGCNA identified 10 correlated gene modules shared between paediatric LRTIs, interpreted as showing similar underlying response mechanisms across the studied respiratory infections.

“Weighted Gene Co-expression Network Analysis (WGCNA) identified 10 correlated gene modules shared between LRTIs showing similar underlying response mechanisms.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The paper includes pathway enrichment findings, including neutrophil degranulation, interferon-gamma signalling, ribosomal proteins and depletion of immune-response pathways in severe SARS-CoV-2 versus healthy children.

    The story refers generally to immune responses and possible treatment targets, but it does not report the specific pathway-enrichment results.

    From Observational paediatric clinical cohort; bulk whole-blood transcriptomic profiling

  • The paper includes computational cellular decomposition, reporting inferred depletion of 22 cell types in severe SARS-CoV-2, 16 in RSV-LRTI and 21 in PTB compared with healthy children.

    The story does not mention the cellular-deconvolution analysis or the inferred cell-type depletion results.

    From cellular decomposition (deconvolution) of bulk whole-blood transcriptomes

  • The observational cross-sectional cohort design limits causal inference about mechanisms or prediction of which children will become severely ill.

    The story mostly uses associational or speculative language, but it does not explicitly acknowledge that the design cannot establish causal mechanisms or prospective risk prediction. This matters particularly for the lead’s reference to which children are at higher risk.

    From Observational paediatric clinical cohort; bulk whole-blood transcriptomic profiling

  • Bulk whole-blood transcriptomes may conflate signals from different cell types, and cellular decomposition is inferred rather than directly measured by single-cell methods.

    The story does not mention the bulk-sample nature of the transcriptomic assay or the limitations of inferred cell-type composition.

    From Observational paediatric clinical cohort; bulk whole-blood transcriptomic profiling; cellular decomposition (deconvoluti

4 things the story did carry across
  • The paper’s central evidence is an observational paediatric whole-blood transcriptomic comparison across healthy, mild/asymptomatic SARS-CoV-2, severe SARS-CoV-2, RSV-LRTI, PTB and other LRTI-related groups.
  • The paper reports more than 5,000 differentially expressed genes at FDR < 0.05 across group comparisons.
  • WGCNA identified 10 correlated gene modules shared between lower respiratory tract infections, interpreted as similar underlying response mechanisms.
  • The paper’s abstract-level evidence lacks external validation or replication of discriminating genes and modules.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoCharacterize whole-blood immune transcriptomic differences between paediatric SARS‑CoV‑2 (mild/asymptomatic and severe) and comparator groups (healthy, RSV‑LRTI, other LRTI, PTB) and identify discriminating genes/pathways.Observational paediatric clinical cohort; bulk whole-blood transcriptomic profilingExpand

In plain English

Observational paediatric cohort study comparing bulk whole-blood transcriptomes across six groups (healthy, mild/asymptomatic SARS-CoV-2, severe SARS-CoV-2, LRTI, RSV-LRTI, PTB) to identify differentially expressed genes, enriched pathways, co-expression modules, and inferred changes in cellular composition that discriminate disease groups and severity.

Key findings

  • Over 5,000 genes were differentially expressed across group comparisons at false discovery rate (FDR) < 0.05.
  • A set of genes (e.g., OLFM4, IFI27, CBX7, IGF2BP3, OTOF) was highlighted as characteristic of severe paediatric SARS-CoV-2 infection.
“Whole blood transcriptomes of healthy children (N = 127) were compared to children with mild/asymptomatic SARS-CoV-2 infection (N = 71) and to children hospitalised with severe SARS-CoV-2 (N = 41), lower respiratory tract illness (LRTI), LRTI due to Respiratory Syncytial Virus (RSV-LRTI) (N = 47), or Pulmonary Tuberculosis (PTB) (N = 47).”
What this piece can’t prove
  • Findings are based on bulk whole-blood transcriptomes, which may conflate signals from multiple cell types; cellular decomposition was inferred rather than measured by single-cell methods.
  • Abstract does not report external validation or replication of the identified discriminating genes or modules.
  • Observational cross-sectional cohort design limits causal inference about mechanisms driving differences between groups.

1 further detail could not be confirmed from the summary.

2human in vivoIdentify shared and distinct co-expression patterns across respiratory infections via WGCNA gene-module analysis.WGCNA co-expression analysisExpand

In plain English

Weighted Gene Co-expression Network Analysis (WGCNA) applied to paediatric whole-blood transcriptomes identified 10 correlated gene modules that were shared across lower respiratory tract infections (LRTIs), interpreted by the authors as indicating similar underlying response mechanisms across the examined LRTI phenotypes.

Key findings

  • WGCNA identified 10 correlated gene modules shared between paediatric LRTIs, interpreted as showing similar underlying response mechanisms across the studied respiratory infections.
“Weighted Gene Co-expression Network Analysis (WGCNA) identified 10 correlated gene modules shared between LRTIs showing similar underlying response mechanisms.”
What this piece can’t prove
  • Unclear how shared modules overlap with differentially expressed genes or enriched pathways reported elsewhere in the paper.

2 further details could not be confirmed from the summary.

3human in vivoInfer relative immune-cell composition differences across disease groups from bulk whole-blood transcriptomes (cellular deconvolution).cellular decomposition (deconvolution) of bulk whole-blood transcriptomesExpand

In plain English

Computational cellular decomposition of bulk whole-blood transcriptomes comparing paediatric disease groups to healthy controls reported depletion of multiple immune cell types: 22 cell types depleted in severe SARS‑CoV‑2, 16 in RSV‑LRTI, and 21 in pulmonary tuberculosis (PTB) relative to healthy children. The abstract does not report which deconvolution algorithm or reference signatures were used, nor statistical thresholds or specific depleted cell-type identities.

Key findings

  • Severe SARS‑CoV‑2 in children showed depletion of 22 inferred immune cell types compared to healthy children based on cellular decomposition of whole-blood transcriptomes.
  • RSV‑LRTI in children showed depletion of 16 inferred immune cell types compared to healthy children.
“Cellular decomposition analysis identified the depletion of 22 cell types in severe SARS-CoV-2, 16 for RSV-LRTI and 21 for PTB compared to healthy children.”
What this piece can’t prove
  • Abstract does not list which specific cell types were depleted in each comparison.

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Immune transcriptomic differences in paediatric patients with SARS-CoV-2 compared to other lower respiratory tract infections

BMC Infectious Diseases · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 40 candidate papers

Selected

Immune transcriptomic differences in paediatric patients with SARS-CoV-2 compared to other lower respiratory tract infections

BMC Infectious Diseases · 2026 · Crossref

Source (opens in a new tab)
Candidate

Immunohematological profiles and viral load among HIV patients with and without malaria coinfection in Northwest Ethiopia

BMC Infectious Diseases · 2026 · Crossref

Source (opens in a new tab)
Candidate

Antibiotic use appropriateness and its determinant factors among pediatric pneumonia patients in selected comprehensive specialized hospitals in Northwest Amhara, 2024: a prospective follow-up study

BMC Infectious Diseases · 2026 · Crossref

Tessa (opens in a new tab)Source (opens in a new tab)

And 34 more candidates considered.